TOMZ Corp.
October 12, 2020

Martin Crous, Ph.D. has recently joined TOMZ Corporation as the new Vice President of Business Development. Crous has been in the Medical Device industry for over twenty years, with experience on both medical device sales and OEM.

His successes have been with turnaround management, start-ups, international business development, and performing detailed business analysis, including market research and competitor intelligence. Crous has extensive experience with training, developing, mentoring, and coaching of sales and marketing professionals, as well as developing new markets by building relationships with medical device companies, surgeons, hospitals, direct sales forces, and independent distributors throughout the world. He has attended over 5000 surgeries in the OR, bringing a world of experience and knowledge to both TOMZ and their clients. Crous holds an MBA from The University of West London and a Ph.D. from Washington International University.

In this position, Crous will contribute to building TOMZ’s business by developing new markets within the U.S. as well as internationally, helping the company and their clients become more successful. His moto has always been, “My Goal – Your Success!” and that is precisely what he plans to achieve for both TOMZ and their clients. Martin Crous is excited to be at TOMZ in support of its current and future clients. “To be trusted with the lives and well-being of patients around the world allows no room for error,” says Crous. “Because of this responsibility, the medical device components that are made here at TOMZ are made to the absolute highest standard with the needs of each client in mind.”

TOMZ Corporation is a top-tier manufacturer of implantable medical devices and instruments for the world's leading medical OEMs. With experience spanning over three decades and a recent facility expansion that has effectively doubled production capacity, allowing for completely integrated manufacturing, TOMZ ensures critical supply chain requirements are met to serve patients globally.